A coronavirus vaccine being developed by scientists at Oxford University induces an immune response to the disease, the first phase of human trials has revealed, Sky News reports. Professor Andrew Pollard, who is leading the study at the University of Oxford, said: "The immune system has two ways of finding and attacking pathogens - antibody and T cell responses. "This vaccine is intended to induce both, so it can attack the virus when it's circulating in the body, as well as attacking infected cells. "We hope this means the immune system will remember the virus, so that our vaccine will protect people for an extended period. Although these results are from phase one of the trials, phase two testing is already under way in the UK and phase three testing on volunteers in Brazil is also taking place.

Source: The Standard July 20, 2020 14:03 UTC